Krystal Biotech KRYS Earnings Call Transcripts

NASDAQ KRYS
$308.81 +2.31 (+0.75%)
At close: Nov 11, 2026 · 4:00 PM EST
6 earnings calls on file for Krystal Biotech, from Q1 2025 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Krystal Biotech Q3 2026 Earnings Call

Nov 2, 2026 7,300 words · 32 min read
  • Stephane PaquetteSenior Vice President of Corporate Development
  • Krish S. KrishnanChairman and Chief Executive Officer
  • Suma KrishnanPresident of Research and Development
  • Laurent GouxExecutive Vice President and General Manager for Europe
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Krystal Biotech Earnings Call Transcripts

Calls6
LatestNov 2, 2026
SinceQ1 2025

Fiscal 2026

Fiscal 2025

All 6 Krystal Biotech transcripts Register to get access to Krystal Biotech’s earnings call transcripts.